Evaluation of the possibility of using the Androscan-MIT device for diagnosis and minimally invasive assessment of conservative therapy outcomes in patients with vasculogenic erectile dysfunction

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Introduction. Erectile dysfunction (ED) remains one of the important issues in modern urology, as it affects not only the quality of life but also the psychological and reproductive health of patients. Diagnostic challenges persist, as there is still no universal, minimally invasive method to evaluate the quality of erection and the efficiency of therapy in patients with a confirmed diagnosis of ED.

Aim. To assess the feasibility of using the Androscan-MIT device as a minimally invasive tool for monitoring the efficiency of conservative treatment in patients with vasculogenic erectile dysfunction.

Materials and Methods. The study included 80 men aged 37 to 61 years with mild to moderate ED and 20 healthy volunteers as a control group. Patients were divided into four groups: group 1 (n=30): patients received local negative pressure therapy (LOD-therapy), low-intensity shockwave therapy (LiSWT), and Avantron chair stimulation (10 sessions); group 2 (n=30): patients received daily phosphodiesterase type 5 inhibitor (PDE5i) therapy at a dose of 5 mg for 2 months; group 3 (n=20): patients received combined therapy including LOD-therapy, LiSWT, Avantron chair stimulation, and platelet-rich plasma (PRP) injections (5 sessions); group 4 (n=20): control group of healthy volunteers.

Therapeutic efficacy was assessed using the IIEF-5 questionnaire (International Index of Erectile Function) and Androscan-MIT measurements before and after treatment.

Results. In Group 3, a significant improvement was observed after therapy: the IIEF-5 score increased to 21.1±2.1, corresponding to a 39.7% rise from baseline.

Repeat nocturnal penile tumescence (NPT) monitoring demonstrated erectile function parameters comparable to those in the control group. The absolute increase in penile diameter reached 12.5±0.4 mm (+48.8% from baseline).

The average number of effective nocturnal erections increased to 4.6±0.4 (+67.6%), and the average duration of each effective erection reached 20.9±1.5 minutes (+36.6%). The total erection time per night was 81.8±5.3 minutes (+74.8% from baseline). In Groups 1 and 2, no statistically significant changes in these parameters were recorded compared to baseline.

Conclusion. The use of the Androscan-MIT device allowed for effective diagnosis of vasculogenic erectile dysfunction and minimally invasive assessment of therapeutic outcomes. The observed improvements following treatment confirm the potential of Androscan-MIT for both diagnostic evaluation and monitoring of conservative therapy efficiency in patients with vasculogenic ED.

Texto integral

Acesso é fechado

Sobre autores

Ruslan Aliev

Altai State Medical University, Ministry of Health of the Russian Federation

Autor responsável pela correspondência
Email: e-mailruslanaliev@bk.ru
ORCID ID: 0000-0003-4464-9162

Ph.D. Student, Department of Urology and Andrology with a Course of Continuing Professional Education

Rússia, Barnaul

Alexander Neimark

Altai State Medical University, Ministry of Health of the Russian Federation

Email: urologagmu@mail.ru
ORCID ID: 0000-0002-5741-6408

Ph.D., MD, Head of the Department of Urology and Andrology with the Course of Continuing Professional Education

Rússia, Barnaul

Andrey Davydov

Altai State Medical University, Ministry of Health of the Russian Federation

Email: andre1763@mail.ru
ORCID ID: 0000-0001-8212-2623

Ph.D., MD, Professor, Department of Urology and Andrology with the Course of Continuing Professional Education

Rússia, Barnaul

Bibliografia

  1. Kapsargin F.P., Volkova G.A., Zukov R.A., Grushkin Yu.V., Pavlovsky S.V., Repina E.V. Analysis of Publicly Available Rehabilitation of Erectile Dysfunction in Young Men. Issues of Diagnostics and Treatment of Urological Diseases. Scientific and Practical Conference of Urologists of Western Siberia. May 12‒13, 2004; Biysk. doi: 10.21886/2308-6424-2020-8-2-78-92. Russian (Капсаргин Ф.П., Волкова Г.А., Зуков Р.А., Грушкин Ю.В., Павловский С.В., Репина Е.В. Анализ общедоступной реабилитации эректильной дисфункции у молодых мужчин. Вопросы диагностики и лечения урологических заболеваний. Научно-практическая конференция урологов Западной Сибири. 12‒13 мая, 2004; Бийск. doi: 10.21886/2308-6424-2020-8-2-78-92).
  2. Pushkar D.Yu., Kamalov A.A., Al-Shukri S.Kh., Erkovich A.A., Kogan M.I., Pavlov V.N., Zhuravlev V.N., Bernikov A.N. Epidemiological study of the prevalence of erectile dysfunction in the Russian Federation. Russian Medical Journal. 2012;20(3):112–115. eLIBRARY ID: 17826950. Russian (Пушкарь Д.Ю., Камалов А.А., Аль-Шукри С.Х., Еркович А.А., Коган М.И., Павлов В.Н., Журавлев В.Н., Берников А.Н. Эпидемиологическое исследование распространенности эректильной дисфункции в Российской Федерации. Русский медицинский журнал. 2012;20(3):112–115. eLIBRARY ID: 17826950).
  3. Efremov E.A., Shekhovtsov S.Yu., Kastrikin Yu.V., Butov A.O., Edoyan T.A. Diagnosis of erectile dysfunction: current state of the problem. Effective Pharmacotherapy. 2019;15(16):38–44. doi: 10.33978/2307-3586-2019-15-16-38-44. Russian (Ефремов Е.А., Шеховцов С.Ю., Кастрикин Ю.В., Бутов А.О., Едоян Т.А. Диагностика эректильной дисфункции. Современное состояние проблемы. Эффективная фармакотерапия. 2019;15(16):38–44. doi: 10.33978/2307-3586-2019-15-16-38-44).
  4. Dedov I.I., Tyulpakov A.N., Chekhonin V.P., Baklaushev V.P., Archakov A.I., Moshkovsky S.A. Personalized medicine: current status and prospects. Annals of the Russian Academy of Medical Sciences. 2012;67(12):4–12. Russian (Дедов И.И., Тюльпаков А.Н., Чехонин В.П., Баклаушев В.П., Арчаков А.И., Мошковский С.А. Персонализированная медицина: современное состояние и перспективы. Вестник Российской академии медицинских наук. 2012;67(12):4–12).
  5. Popov S.V., Orlov I.N., Grin E.A., Malevich S.M., Gulko A.M., Topuzov T.M., Kyzlasov P.S., Povelitsa E.A. New technologies and approaches in the diagnosis and treatment of erectile dysfunction. Urology Herald. 2020;8(2):78–92. doi: 10.21886/2308-6424-2020-8-2-78-92. Russian (Попов С.В., Орлов И.Н., Гринь Е.А., Малевич С.М., Гулько А.М., Топузов Т.М., Кызласов П.С., Повелица Э.А. Новые технологии и подходы в диагностике и лечении эректильной дисфункции. Вестник урологии. 2020;8(2):78–92. https://doi.org/10.21886/2308-6424-2020-8-2-78-92).
  6. Vardi Y., Appel B., Jacob G., Massarwi O., Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur. Urol. 2010;58:243–248. doi: 10.1016/j.eururo.2010.04.004
  7. Drury R., Natale C., Hellstrom W.J.G. Reviewing the evidence for shockwave- and cell-based regenerative therapies in the treatment of erectile dysfunction. Ther. Adv. Urol. 2021;13, doi: 10.1177/17562872211002059
  8. Daeschler S.C., Harhaus L., Schoenle P., Boecker A., Kneser U., Bergmeister K.D. Ultrasound and shock-wave stimulation to promote axonal regeneration following nerve surgery: A systematic review and meta-analysis of preclinical studies. Sci. Rep. 2018;8:3168. doi: 10.1038/s41598-018-21540-5
  9. Usta M.F., Gabrielson A.T., Bivalacqua T.J. Low-intensity extracorporeal shockwave therapy in the treatment of erectile dysfunction following radical prostatectomy: A critical review. Int. J. Impot. Res. 2019;31:231–238. doi: 10.1038/s41443-019-0121-3
  10. Vardi Y.. Appel B., Jacob G., Massarwi O., Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur. Urol. 2010;58:243–248. doi: 10.1016/j.eururo.2010.04.004
  11. Drury R., Natale C., Hellstrom W.J.G. Reviewing the evidence for shockwave- and cell-based regenerative therapies in the treatment of erectile dysfunction. Ther. Adv. Urol. 2021;13. doi: 10.1177/17562872211002059
  12. Daeschler S.C., Harhaus L., Schoenle P., Boecker A., Kneser U., Bergmeister K.D. Ultrasound and shock-wave stimulation to promote axonal regeneration following nerve surgery: A systematic review and meta-analysis of preclinical studies. Sci. Rep. 2018;8:3168. doi: 10.1038/s41598-018-21540-5
  13. Usta M.F., Gabrielson A.T., Bivalacqua T.J. Low-intensity extracorporeal shockwave therapy in the treatment of erectile dysfunction following radical prostatectomy: A critical review. Int. J. Impot. Res. 2019;31:231–238. doi: 10.1038/s41443-019-0121-3
  14. Lederer O. Surgical Device. U.S. Patent 1,225,341, 18 May 1917.
  15. Witherington R. Vacuum constriction device for management of erectile impotence. J. Urol. 1989;141:320–322. doi: 10.1016/S0022-5347(17)40752-X
  16. Diederichs W., Kaula N.F., Lue T.F., Tanagho E.A. The effect of subatmospheric pressure on the simian penis. J. Urol. 1989;142:1087–1089 doi: 10.1016/s0022-5347(17)39001-8
  17. Lin H., Wang R. The science of vacuum erectile device in penile rehabilitation after radical prostatectomy. Transl. Androl. Urol. 2013;2:61–66. doi: 10.3978/j.issn.2223-4683.2013.01.04
  18. Yuan J., Lin H., Li P., Zhang R., Luo A., Berardinelli F., Dai Y., Wang R. Molecular mechanisms of vacuum therapy in penilerehabilitation: A novel animal study. Eur. Urol. 2010;58:773–780. doi: 10.1016/j.eururo.2010.07.005
  19. Fatkhullina L.S., Dzhordzhikiya R.K., Rakhimullin I.M., et al. The role of platelet concentrate transfusion in cardiac surgery. Bulletin of Contemporary Clinical Medicine. 2014;7(5):56–59. doi: 10.17709/2409-2231-2019-6-3-7. Russian (Фатхуллина Л.С., Джорджикия Р.К., Рахимуллин И.М. и др. Роль трансфузии концентрата тромбоцитов при кардиохирургических операциях. Вестник современной клинической медицины. 2014;7(5):56–59. doi: 10.17709/2409-2231-2019-6-3-7).
  20. Stiles C.D. The molecular biology of platelet-derived growth factor. Cell. 1983;33(3):653–55. doi: 10.1016/0092-8674(83)90008-9.
  21. Marx R.E., Carlson E.R., Eichstaedt R.M., Schimmele S.R., Strauss J.E., Georgeff K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med. Oral Pathol Oral Radiol. Endod. 1998;85(6):638–646. doi: 10.1016/s1079-2104(98)90029-4.
  22. Weiser L., Bhargava M., Attia E., Torzilli P.A. Effect of serum and platelet-derived growth factor on chondrocytes grown in collagen gels. Tissue Eng. 1999;5(6):533–44. doi: 10.1089/ten.1999.5.533.
  23. Wu Y.N., Wu C.C., Sheu M.T. et al. Optimization of platelet-rich plasma and its effects on the recovery of erectile function after bilateral cavernous nerve injury in a rat model. J of Tissue Eng Regen Med. 2013;16(10):E294-E304. doi: 10.1002/term.1806. doi: 10.1002/term.1806.
  24. Patent 2514639 Russian Federation, IPC A61K 35/16, IPC A61R 15/10. Method of treatment of erectile dysfunction / applicants and patent holders – Chaly M. E., Vilkin Ya. E., Epifanova M. V.-no. 2012153883/15; declared 13.12.12; published 27.04.14, Bullyuten No. 12. Russian (Патент 2514639 Российская Федерация, МПК А61К 35/16, МПК А61Р 15/10. Способ лечения эректильной дисфункции /заявители и патентообладатели – Чалый М.Е., Вилькин Я. Е., Епифанова М.В. № 2012153883/15; заявл. 13.12.12; опубл. 27.04.14, Бюл. № 12).

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2025